Literature DB >> 28265818

The patients' view: impact of the extent of resection, intraoperative imaging, and awake surgery on health-related quality of life in high-grade glioma patients-results of a multicenter cross-sectional study.

Katrin Nickel1, Mirjam Renovanz2, Jochem König3, Linda Stöckelmaier1, Anne-Katrin Hickmann4, Minou Nadji-Ohl5, Jens Engelke1, Elke Weimann6, Dirk Freudenstein6, Oliver Ganslandt5, Lars Bullinger7, Christian Rainer Wirtz1, Jan Coburger8.   

Abstract

The objective of the present study is to assess the influence of extent of resection (EoR), use of intraoperative imaging, and awake surgery on health-related quality of life (HRQoL) in high-grade glioma (HGG) patients in a prospective multicenter study. We analyzed 170 surgeries of patients suffering from a HGG. During the first year after resection, HRQoL was evaluated using the European Organization of Research and Treatment of Cancer Core Questionnaire C30 and Brain Neoplasm 20 questionnaires. We assessed the influence of EoR; awake surgery; and use of 5-aminolevulinic acid (5-ALA), intraoperative MRI (iMRI), and their combination on sum scores for function and symptoms as well as several neurological single items. In mixed-model analyses, adjustments for age, Karnofsky performance status (KPS), and eloquent location were performed. In the mixed model, EoR generally did not significantly influence HRQoL (p = 0.10). Yet, patients receiving subtotal resection (STR) vs. patients with biopsy showed significantly better QoL and role and cognitive functions (p = 0.04, p = 0.02, and p < 0.01, respectively). The combination of iMRI and 5-ALA reached the highest EoR (95%) followed by iMRI alone (94%), 5-ALA alone (74%), and no imaging (73%). Thereby, neurological symptoms were lowest and functioning score highest after combined use of iMRI and 5-ALA, without reaching significance (p = 0.59). Despite lower scores in emotional function (59 vs. 46, p = 0.24), no significant impact of awake surgery on HRQoL was found (p = 0.70). In HGG patients, STR compared to biopsy was significantly associated with better HRQoL and fewer neurological symptoms in this series. An escalated use of intraoperative imaging increased EoR with stable or slightly better HRQoL and fewer neurological symptoms. Based on HRQoL, awake surgery was a well-tolerated and safe method in our series.

Entities:  

Keywords:  5-Aminolevulinic acid; Awake surgery; Extent of resection; Health-related quality of life; High-grade glioma; Intraoperative magnetic resonance imaging; Karnofsky performance status

Mesh:

Substances:

Year:  2017        PMID: 28265818     DOI: 10.1007/s10143-017-0836-x

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  33 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30?

Authors:  A Hinz; J Einenkel; S Briest; J-U Stolzenburg; K Papsdorf; S Singer
Journal:  Eur J Cancer Care (Engl)       Date:  2012-05-25       Impact factor: 2.520

3.  The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

Review 4.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

5.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

6.  Quality of life in patients with intracranial tumors: does tumor laterality matter?

Authors:  Christina Drewes; Lisa Millgård Sagberg; Asgeir Store Jakola; Ole Solheim
Journal:  J Neurosurg       Date:  2016-03-25       Impact factor: 5.115

Review 7.  Patient response to awake craniotomy - a summary overview.

Authors:  Monika Milian; Marcos Tatagiba; Guenther C Feigl
Journal:  Acta Neurochir (Wien)       Date:  2014-03-05       Impact factor: 2.216

8.  Quality of life before and after total laryngectomy: results of a multicenter prospective cohort study.

Authors:  Susanne Singer; Helge Danker; Orlando Guntinas-Lichius; Jens Oeken; Friedemann Pabst; Juliane Schock; Hans-Joachim Vogel; Eberhard F Meister; Cornelia Wulke; Andreas Dietz
Journal:  Head Neck       Date:  2013-06-01       Impact factor: 3.147

9.  Assessing health-related quality of life in patients with breast cancer: a systematic and standardized comparison of available instruments using the EMPRO tool.

Authors:  Stefano Maratia; Sergio Cedillo; Javier Rejas
Journal:  Qual Life Res       Date:  2016-04-05       Impact factor: 4.147

10.  The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients.

Authors:  Chantal Quinten; Corneel Coens; Irina Ghislain; Efstathios Zikos; Mirjam A G Sprangers; Jolie Ringash; Francesca Martinelli; Divine E Ediebah; John Maringwa; Bryce B Reeve; Eva Greimel; Madeleine T King; Kristin Bjordal; Hans-Henning Flechtner; Joseph Schmucker-Von Koch; Martin J B Taphoorn; Joachim Weis; Hans Wildiers; Galina Velikova; Andrew Bottomley
Journal:  Eur J Cancer       Date:  2015-11-19       Impact factor: 9.162

View more
  7 in total

1.  What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?

Authors:  Anne Clavreul; Ghislaine Aubin; Matthieu Delion; Jean-Michel Lemée; Aram Ter Minassian; Philippe Menei
Journal:  J Neurooncol       Date:  2021-01-04       Impact factor: 4.130

2.  AI-Assisted In Situ Detection of Human Glioma Infiltration Using a Novel Computational Method for Optical Coherence Tomography.

Authors:  Ronald M Juarez-Chambi; Carmen Kut; Jose J Rico-Jimenez; Kaisorn L Chaichana; Jiefeng Xi; Daniel U Campos-Delgado; Fausto J Rodriguez; Alfredo Quinones-Hinojosa; Xingde Li; Javier A Jo
Journal:  Clin Cancer Res       Date:  2019-07-17       Impact factor: 12.531

Review 3.  Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.

Authors:  Tiffany A Eatz; Daniel G Eichberg; Victor M Lu; Long Di; Ricardo J Komotar; Michael E Ivan
Journal:  J Neurooncol       Date:  2022-01-06       Impact factor: 4.130

4.  Quality of life following awake surgery depends on ability of executive function, verbal fluency, and movement.

Authors:  Riho Nakajima; Masashi Kinoshita; Hirokazu Okita; Mitsutoshi Nakada
Journal:  J Neurooncol       Date:  2021-11-20       Impact factor: 4.130

5.  Glioma surgery under awake condition can lead to good independence and functional outcome excluding deep sensation and visuospatial cognition.

Authors:  Riho Nakajima; Masashi Kinoshita; Hirokazu Okita; Tetsutaro Yahata; Mitsutoshi Nakada
Journal:  Neurooncol Pract       Date:  2018-12-20

6.  Fluorescent Guided Surgery in the Surgical Management of Glioma: The Dawn of a New Era.

Authors:  Kostas N Fountas
Journal:  Brain Sci       Date:  2020-04-16

7.  Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery.

Authors:  Philip C De Witt Hamer; Philip C De Witt Hamer; Martin Klein; Shawn L Hervey-Jumper; Jeffrey S Wefel; Mitchel S Berger
Journal:  Neurosurgery       Date:  2021-03-15       Impact factor: 4.654

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.